Next Generation Cancer Diagnostics Market Size Report, 2032

Next Generation Cancer Diagnostics Market – By Product & Service, By Technology, By Cancer Type, By Application, By End Use – Global Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising prevalence of cancer

3.2.1.2&nbsp;&nbsp;&nbsp; Growing advancement in diagnostic technologies

3.2.1.3&nbsp;&nbsp;&nbsp; Increased investments in cancer research

3.2.1.4&nbsp;&nbsp;&nbsp; Growing awareness and screening programs

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High costs of advanced diagnostics technologies

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulations and lengthy approval processes

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Future market trends

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Pricing analysis

3.7&nbsp;&nbsp;&nbsp; Regulatory landscape

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product &amp; Service, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Products

5.2.1&nbsp;&nbsp;&nbsp; Instruments

5.2.2&nbsp;&nbsp;&nbsp; Kits &amp; consumables

5.3&nbsp;&nbsp;&nbsp; Services

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Next-generation sequencing (NGS)

6.3&nbsp;&nbsp;&nbsp; Polymerase chain reaction (PCR)

6.4&nbsp;&nbsp;&nbsp; DNA microarrays

6.5&nbsp;&nbsp;&nbsp; Multiplexing

6.6&nbsp;&nbsp;&nbsp; Other technologies

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Cancer Type, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Breast cancer

7.3&nbsp;&nbsp;&nbsp; Lung cancer

7.4&nbsp;&nbsp;&nbsp; Colorectal cancer

7.5&nbsp;&nbsp;&nbsp; Prostate cancer

7.6&nbsp;&nbsp;&nbsp; Cervical cancer

7.7&nbsp;&nbsp;&nbsp; Liver cancer

7.8&nbsp;&nbsp;&nbsp; Other cancer types

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Screening and early detection

8.3&nbsp;&nbsp;&nbsp; Prognostics and monitoring

8.4&nbsp;&nbsp;&nbsp; Therapy selection

8.5&nbsp;&nbsp;&nbsp; Recurrence monitoring

8.6&nbsp;&nbsp;&nbsp; Other applications

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Hospitals &amp; clinics

9.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

9.4&nbsp;&nbsp;&nbsp; Academic &amp; research institutions

9.5&nbsp;&nbsp;&nbsp; Other end users

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp;U.S.

10.2.2&nbsp;&nbsp;&nbsp;Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp;Germany

10.3.2&nbsp;&nbsp;&nbsp;UK

10.3.3&nbsp;&nbsp;&nbsp;France

10.3.4&nbsp;&nbsp;&nbsp;Italy

10.3.5&nbsp;&nbsp;&nbsp;Spain

10.3.6&nbsp;&nbsp;&nbsp;Netherlands

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp;China

10.4.2&nbsp;&nbsp;&nbsp;Japan

10.4.3&nbsp;&nbsp;&nbsp;India

10.4.4&nbsp;&nbsp;&nbsp;Australia

10.4.5&nbsp;&nbsp;&nbsp;South Korea

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp;Brazil

10.5.2&nbsp;&nbsp;&nbsp;Mexico

10.5.3&nbsp;&nbsp;&nbsp;Argentina

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp;South Africa

10.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp;UAE

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Agilent

11.2&nbsp;&nbsp;&nbsp; Almac

11.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories

11.4&nbsp;&nbsp;&nbsp; Exact Sciences

11.5&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche

11.6&nbsp;&nbsp;&nbsp; GenScript

11.7&nbsp;&nbsp;&nbsp; Guardant Health

11.8&nbsp;&nbsp;&nbsp; Illumina

11.9&nbsp;&nbsp;&nbsp; Karkinos Healthcare

11.10&nbsp;&nbsp;&nbsp; Qiagen

11.11&nbsp;&nbsp;&nbsp; Koninklijke Philips

11.12&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

&nbsp;&nbsp;&nbsp;

Next Generation Cancer Diagnostics Market

Get a free sample of this report